|
|
Home>> India Company >> A>> Aventis Crop Science
Aventis Crop Science India
Aventis Crop Science India is a pharmaceutical major engaged in the manufacturing of human therapeutic medicines as well as agrochemicals. The present company is the result of a merger between Rhone-Poulenc SA of France and Hoechst AG of Germany. Aventis Crop Science India is an India member of the multi-national Sanofi-Aventis Group. Mr. Vijay Mallya is the current chairman. The company is listed in the Indian BSE and NSE stock exchanges.
Revenue from Agriculture Products
Most of the revenues of Sanofi-Aventis's Indian subsidiary is sourced from its agriculture oriented products. An overwhelming part comes from crop protection business lines. Seed and crop yield improvement techniques are the mainstay of the company. Turf and amenity products also add to the bottomline. The pesticide business is being phased out.
Medicines for Humans
Sanofi- Aventis also makes medicinal products for humans. The corporation has strengths in 7 medicinal fields:
a. Thrombosis
b. Central Nervous System Disorders
c. Internal Medicine
d. Vaccines
e. Cardiovascular Diseases
f. Oncology
g. Metabolic Disorders
New Revenue Growth
Aventis Crop Science India is concentrating on biotechnology products to sustain the company revenues in the future. New biotechnology based agricultural products make up approximately 15% of the company's total profits. Aventis Crop Science India aims to make it 50% by the next 5 years. The list of prime revenue generating products include the fungicide, bromoconazole and the maize herbicide Balance or isoxaflutole. The present product spectrum include insecticides like Spark, Hostathion, and Decis.
Aventis Crop Science India presently has approximately 14% share of the Indian domestic market.
Contact Address
Sanofi-Aventis
54/A, Sir Mathuradas Vasanji Road,
Andheri East,
Mumbai 400 093
India
|
|
|
